Page last updated: 2024-08-24

fluorodopa f 18 and Atrophy

fluorodopa f 18 has been researched along with Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burghaus, L; Heiss, WD; Herholz, K; Hilker, R; Jacobs, AH; Kalbe, E; Klein, JC; Thomas, AV; Weisenbach, S1
Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Ishikawa, T; Przedborski, S; Spetsieris, P; Takikawa, S1

Trials

1 trial(s) available for fluorodopa f 18 and Atrophy

ArticleYear
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.
    Neurology, 2005, Dec-13, Volume: 65, Issue:11

    Topics: Acetates; Acetylcholine; Acetylcholinesterase; Aged; Atrophy; Binding, Competitive; Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Neuropsychological Tests; Parkinson Disease; Piperidines; Positron-Emission Tomography; Synaptic Transmission

2005

Other Studies

1 other study(ies) available for fluorodopa f 18 and Atrophy

ArticleYear
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
    Neurology, 1994, Volume: 44, Issue:9

    Topics: Adult; Atrophy; Brain; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Syndrome; Tomography, Emission-Computed

1994